Palisade Bio (PALI) director Robert Baltera Jr. files initial Form 3

Rhea-AI Filing Summary

PALISADE BIO, INC. director Robert Baltera Jr. has filed an initial Form 3, which is a statement of beneficial ownership for insiders. The data provided shows no reported buy, sell, exercise, gift, tax withholding, or restructuring transactions, indicating purely administrative reporting at this stage.

Key Figures

Insider buy transactions: 0 transactions Insider sell transactions: 0 transactions Net buy/sell shares: 0 shares

3 metrics

Insider buy transactions 0 transactions BuyCount in Form 3 transaction summary

Insider sell transactions 0 transactions SellCount in Form 3 transaction summary

Net buy/sell shares 0 shares NetBuySellShares marked neutral

Key Terms

Form 3, reporting person, beneficial ownership

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

"The reporting person is Robert Baltera Jr., identified as a director"

beneficial ownership regulatory

"an initial Form 3, which is a statement of beneficial ownership"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Baltera Robert Jr.

(Last) (First) (Middle)

C/O PALISADE BIO, INC.

4600 SOUTH SYRACUSE STREET, SUITE 900

(Street)

DENVER COLORADO 80237

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/10/2026

3. Issuer Name and Ticker or Trading Symbol
PALISADE BIO, INC. [ PALI ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Ryker Willie, Attorney-in-Fact for Robert Baltera	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Palisade Bio (PALI) disclose in this Form 3?

The Form 3 shows director Robert Baltera Jr. as a reporting person of Palisade Bio. It is an initial statement of beneficial ownership and, in this data, does not list any insider buy, sell, or derivative transactions.

Who is the reporting person on Palisade Bio (PALI) Form 3?

The reporting person is Robert Baltera Jr., identified as a director of Palisade Bio, Inc. He is not listed as an officer or 10% owner in this filing, indicating his role is specifically as a board member.

Does this Palisade Bio (PALI) Form 3 show any insider stock purchases or sales?

No transactions are shown in this data. The transaction summary reports zero buys, zero sells, zero exercises, and zero gifts, indicating the filing is administrative and not tied to new trading activity in Palisade Bio shares.

What is the net trading direction in this Palisade Bio (PALI) Form 3?

The transaction summary lists a neutral net buy/sell direction with netBuySellShares at zero. This reflects that no insider trading activity, such as purchases, sales, or derivative exercises, is reported within the scope of this Form 3 data.

Are there any derivative positions reported for Palisade Bio (PALI) in this Form 3?

The derivative summary is empty in this dataset, and derivativeTransactionCount is zero. That means no options, warrants, or other derivative securities are detailed here for Robert Baltera Jr. in connection with this specific initial Form 3 filing.